delivering cardiac repair

Innovation

 
145.54_4.4_10X_pepsin_150ms_5_c2.JPG
 

introduction

Solutions for the Heart

Ventrix is a clinical-stage company focused on the development of tissue engineering products for
cardiovascular disease.

 
 
 
 
H165_5.2_10x_J (1).jpg
 

engineering

Transformative Medicine

We are working on novel and innovative biomaterials to harness endogenous repair to improve cardiac function and outcomes for those suffering from Heart Failure.

The VentriGel cardiac repair scaffold is a biomaterial designed specifically for repair of damaged myocardium.

 

NEWS

Ventrix has initiated a Phase 1 clinical study for VentriGel, a first-in-class, off-the-shelf, biomaterial scaffold, in heart failure patients with left ventricular dysfunction after a myocardial infarction (heart attack).

 

Contact

Ventrix is available for partnering opportunities.